These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7842491)

  • 1. Modulation of topoisomerase activities by tumor necrosis factor.
    Baloch Z; Cohen S; Fresa K; Coffman FD
    Cell Immunol; 1995 Jan; 160(1):98-103. PubMed ID: 7842491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of topoisomerase inhibitor-induced DNA strand breakage and cytotoxicity by tumor necrosis factor: enhancement of topoisomerase activity as a mechanism of potentiation.
    Utsugi T; Mattern MR; Mirabelli CK; Hanna N
    Cancer Res; 1990 May; 50(9):2636-40. PubMed ID: 2158396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic interactions between tumor necrosis factor and inhibitors of DNA topoisomerase I and II.
    Baloch Z; Cohen S; Coffman FD
    J Immunol; 1990 Nov; 145(9):2908-13. PubMed ID: 2170526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid increase in the activity of DNA topoisomerase I, but not topoisomerase II, in HL-60 promyelocytic leukemia cells treated with a phorbol diester.
    Gorsky LD; Cross SM; Morin MJ
    Cancer Commun; 1989; 1(2):83-92. PubMed ID: 2561736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abrogation of TNF-mediated cytotoxicity by space flight involves protein kinase C.
    Woods KM; Chapes SK
    Exp Cell Res; 1994 Mar; 211(1):171-4. PubMed ID: 8125155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF-mediated cytotoxicity of L929 cells: role of staurosporine in enhancement of cytotoxicity and translocation of protein kinase C isozymes.
    O'Connell MA; Kelleher D; Liskamp RM; Hall N; O'Neill LA; Long A
    Cytokine; 1997 Feb; 9(2):83-92. PubMed ID: 9071558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of protein kinase C in regulating tumor necrosis factor alpha-stimulated progesterone production in rat preovulatory follicles in vitro.
    Sancho-Tello M; Terranova PF
    Endocrinology; 1991 Mar; 128(3):1223-8. PubMed ID: 1847853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic antitumor effects of topoisomerase inhibitors and natural cell-mediated cytotoxicity.
    Utsugi T; Demuth S; Hanna N
    Cancer Res; 1989 Mar; 49(6):1429-33. PubMed ID: 2538225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human natural killer cell activity by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine is an early but post-binding event.
    Steele TA; Brahmi Z
    J Immunol; 1988 Nov; 141(9):3164-9. PubMed ID: 3262683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor induction of endothelial cell surface antigens is independent of protein kinase C activation or inactivation. Studies with phorbol myristate acetate and staurosporine.
    Ritchie AJ; Johnson DR; Ewenstein BM; Pober JS
    J Immunol; 1991 May; 146(9):3056-62. PubMed ID: 1707932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nickel and skin irritants up-regulate tumor necrosis factor-alpha mRNA in keratinocytes by different but potentially synergistic mechanisms.
    Lisby S; Müller KM; Jongeneel CV; Saurat JH; Hauser C
    Int Immunol; 1995 Mar; 7(3):343-52. PubMed ID: 7794816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-gamma induces the expression of the genes for MHC class II I-A beta and tumor necrosis factor through a protein kinase C-independent pathway.
    Celada A; Maki RA
    J Immunol; 1991 Jan; 146(1):114-20. PubMed ID: 1845803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth arrest of the breast cancer cell line, T47D, by TNF alpha; cell cycle specificity and signal transduction.
    Pusztai L; Lewis CE; McGee JO
    Br J Cancer; 1993 Feb; 67(2):290-6. PubMed ID: 8381656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differing roles of protein kinase C on the antiproliferative effects of tumor necrosis factor alpha and beta on LoVo cells.
    Matsubara N; Fuchimoto S; Orita K
    Pathobiology; 1990; 58(3):168-71. PubMed ID: 2222808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inhibition of IL-1 and TNF-alpha mRNA expression by agents which block second messenger pathways in murine macrophages.
    Kovacs EJ; Radzioch D; Young HA; Varesio L
    J Immunol; 1988 Nov; 141(9):3101-5. PubMed ID: 3262679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmed cell death (apoptosis) of mouse fibroblasts is induced by the topoisomerase II inhibitor etoposide.
    Mizumoto K; Rothman RJ; Farber JL
    Mol Pharmacol; 1994 Nov; 46(5):890-5. PubMed ID: 7969076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of protein kinase C activator and inhibitor on release of tumor necrosis factor from mouse peritoneal macrophages].
    Hu ZL; Qian DH
    Zhongguo Yao Li Xue Bao; 1993 Mar; 14(2):183-6. PubMed ID: 8352018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors.
    Bertrand R; Solary E; Jenkins J; Pommier Y
    Exp Cell Res; 1993 Aug; 207(2):388-97. PubMed ID: 7688316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride (H-7) inhibits PMA-induced promiscuous cytolytic activity but not specific cytolytic activity by a cloned cytolytic T lymphocyte.
    Howcroft TK; Lindquist RR
    Biochem Biophys Res Commun; 1991 Sep; 179(2):720-5. PubMed ID: 1898396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor gene expression is mediated by protein kinase C following activation by ionizing radiation.
    Hallahan DE; Virudachalam S; Sherman ML; Huberman E; Kufe DW; Weichselbaum RR
    Cancer Res; 1991 Sep; 51(17):4565-9. PubMed ID: 1873801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.